Amarnath Securities Board of Directors

Get the latest insights into the leadership at Amarnath Securities. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Omkar Herlekar Pravin Non Exe.Non Ind.Director
Mr. Ajay Hareshlal Sukhwani Ind. Non-Executive Director
Ms. Chandni Kishan Makhija Ind. Non-Executive Director
Mr. Naresh Dharma Padir Whole Time Director

Amarnath Securities Share price

AMARSEC

11.69

0.18 (-1.52%)
Last updated on 1 Sep, 2025 | 15:29 IST
BUYSELL
Today's High

12.68

Today's Low

11.27

52 Week Low

10.15

52 Week High

43.70

The current prices are delayed, login to your account for live prices

Amarnath Securities FAQs

The board at Amarnath Securities consists of experienced professionals, including Dr. Omkar Herlekar Pravin , Mr. Ajay Hareshlal Sukhwani , and others, overseeing the company’s strategic and corporate governance.

Directors at Amarnath Securities are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Omkar Herlekar Pravin is the current chairman at Amarnath Securities.

Executive directors at Amarnath Securities are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Amarnath Securities adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Amarnath Securities, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.